ArticleFrontiers in neurology
Explainable machine learning for predicting lower extremity deep vein thrombosis in traumatic brain injury patients: development of a SHAP-guided Random Forest model.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower extremity deep vein thrombosis (LEDVT) is a common and clinically important complication after traumatic brain injury (TBI). Early identification of patients at increased thrombotic risk remains challenging. We aimed to develop and internally validate an interpretable machine-learning model for predicting LEDVT in patients with TBI. Methods: In this retrospective observational study, we analyzed 248 consecutive patients with TBI treated at Qinghai University Affiliated Hospital between August 2024 and December 2025. Patients were randomly assigned to a training cohort ( Results: LEDVT occurred in 88 of 248 patients (35.5%). LASSO retained six variables for model development: age, platelet count, D-dimer, interleukin, lower limb fracture, and prophylactic anticoagulation. In multivariable logistic regression, D-dimer, interleukin, lower limb fracture, and prophylactic anticoagulation were significantly associated with LEDVT, whereas age and platelet count showed borderline associations. In the validation cohort, the Random Forest model showed strong discrimination, with an area under the receiver operating characteristic curve of 0.931 (95% CI 0.878-0.985), sensitivity of 78.8%, specificity of 95.1%, accuracy of 87.8%, precision of 92.9%, and F1 score of 0.852. SHAP analysis identified D-dimer, interleukin, prophylactic anticoagulation, age, platelet count, and lower limb fracture as the main contributors to model output. Conclusion: An interpretable Random Forest model based on routinely available clinical and laboratory variables showed good internal predictive performance for LEDVT after TBI. After external validation, this approach may help support early risk stratification and individualized surveillance in patients at increased thrombotic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.